Back to School: How biopharma can reboot drug development. Access exclusive analysis here

GlycoPEG-GCSF: Phase I data

In a Phase I trial in 36 healthy volunteers 6 mg of GlycoPEG-GCSF demonstrated

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE